← Open Payments lookup

KEVIN MAYS: Open Payments

NPI 1598735144 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$79,465 in 264 payments from 19 companies in 2025. Trend: 2023 $120,225 · 2024 $87,275 · 2025 $79,465

Speaker / faculty: $36,255Honoraria: $22,800Consulting: $10,408Travel & lodging: $5,228Food & beverage: $4,771Education: $4
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.50$26,568
Neurocrine BioSciences, Inc.31$24,135
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)46$21,960
ABBVIE INC.31$4,907
Vanda Pharmaceuticals Inc.17$425
Otsuka America Pharmaceutical, Inc.23$400
E.R. Squibb & Sons, L.L.C.16$196
Takeda Pharmaceuticals U.S.A., Inc.7$168
Collegium Pharmaceutical, Inc.15$154
Almatica Pharma LLC5$99

Products named: Qelbree, INGREZZA, CAPLYTA, VRAYLAR, HETLIOZ, REXULTI, COBENFY, ABILIFY ASIMTUFII.

Industry payments across KS — which companies pay providers there.